Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
28.1M
-
Shares change
-
+3.39M
-
Total reported value, excl. options
-
$64.2M
-
Value change
-
+$7.67M
-
Put/Call ratio
-
0.37
-
Number of buys
-
23
-
Number of sells
-
-31
-
Price
-
$2.29
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q3 2014
81 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q3 2014.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.1M shares
.
Largest 10 shareholders include FMR LLC (4.32M shares), Broadfin Capital, LLC (3.53M shares), NATIXIS (3.15M shares), VANGUARD GROUP INC (2.32M shares), BAKER BROS. ADVISORS LP (1.62M shares), DEUTSCHE BANK AG\ (1.49M shares), BlackRock Fund Advisors (1.42M shares), MILLENNIUM MANAGEMENT LLC (945K shares), DIMENSIONAL FUND ADVISORS LP (871K shares), and HealthCor Management, L.P. (850K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.